Celldex Therapeutics (CLDX) is a clinical-stage biotechnology company that focuses on developing targeted therapies for rare ...

YOUR favourite spooky treat might be harbouring an unwanted trick, an expert has warned. Some ingredients lurking in your ...

For more than 50 years Martyn Pring's (right) life was dominated by an 'uncontrollable' urge to itch - and nothing doctors ...

Leerink Partners analyst Thomas Smith maintained a Buy rating on Celldex (CLDX – Research Report) on October 14 and set a price target of ...

With positive results for patients with the chronic skin condition, Jasper Therapeutics’ briquilimab is looking to take on ...

Hives, also known as urticaria, affects about 20% of people at some time during their lives, including U.S. presidential candidate Kamala Harris.

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

KIT antibody has shown promise in a Phase 1b/2a test in people with certain irritable skin conditions, sending its shares ...

On Monday, Jasper Therapeutics Inc (NASDAQ:JSPR) stock is trading higher after the company reported preliminary data from its ...

Jasper Therapeutics has reported complete responses in 10 of the 12 chronic hives patients who received the high dose of its ...

No serious adverse events; no grade 3 or higher adverse events reported Initial data from BEACON study expected week of January 6 th, 2025, including 180mg Q8W cohort Company to host conference call ...

Jasper Therapeutics Shares Encouraging Data from SPOTLIGHT Study on Briquilimab for Chronic Inducible Urticaria ...